These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 34053365)

  • 1. Immune thrombocytopenia and COVID-19: Case report and review of literature.
    Alonso-Beato R; Morales-Ortega A; Fernández FJH; Morón AIP; Ríos-Fernández R; Rubio JLC; Centeno NO
    Lupus; 2021 Aug; 30(9):1515-1521. PubMed ID: 34053365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes and management of immune thrombocytopenia secondary to COVID-19: Cleveland clinic experience.
    Kewan T; Gunaratne TN; Mushtaq K; Alayan D; Daw H; Haddad A
    Transfusion; 2021 Jul; 61(7):2014-2018. PubMed ID: 33724474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of pre-delivery medication treatment on delivery outcome in patients with primary immune thrombocytopenia: a cohort study.
    Xu X; Liang MY; Zhao LR; Wang JL; Zhang XH
    Platelets; 2024 Dec; 35(1):2380366. PubMed ID: 39087677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
    Watts RG
    Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of sarcoidosis and immune thrombocytopenia: presentation and outcome in a series of 20 patients.
    Mahévas M; Chiche L; Uzunhan Y; Khellaf M; Morin AS; Le Guenno G; Péronne V; Affo L; Lidove O; Boutboul D; Dion G; Ducroix JP; Papo T; Pacheco Y; Schleinitz N; Michel M; Godeau B; Valeyre D
    Medicine (Baltimore); 2011 Jul; 90(4):269-278. PubMed ID: 21694642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review.
    Bidari A; Asgarian S; Pour Mohammad A; Naderi D; Anaraki SR; Gholizadeh Mesgarha M; Naderkhani M
    Eur J Haematol; 2023 Apr; 110(4):335-353. PubMed ID: 36562217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of predictive factors for response to intravenous immunoglobulin treatment in children with immune thrombocytopenia.
    Morimoto Y; Yoshida N; Kawashima N; Matsumoto K; Kato K
    Int J Hematol; 2014; 99(5):597-602. PubMed ID: 24573984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immune thrombocytopenia preceded by asymptomatic COVID-19 infection].
    Ochiai T; Ando J; Harada S; Hiki M; Ando M; Komatsu N
    Rinsho Ketsueki; 2021; 62(1):58-60. PubMed ID: 33551428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe Thrombocytopenic Purpura Associated with COVID-19 in a Pediatric Patient.
    Marinescu AR; Lazureanu VE; Musta VF; Nicolescu ND; Mocanu A; Cut TG; Muresan CO; Tudoran C; Licker M; Laza R
    Infect Drug Resist; 2022; 15():3405-3415. PubMed ID: 35794926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome and management in neonatal thrombocytopenia due to maternal idiopathic thrombocytopenic purpura.
    van der Lugt NM; van Kampen A; Walther FJ; Brand A; Lopriore E
    Vox Sang; 2013 Oct; 105(3):236-43. PubMed ID: 23782272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe immune thrombocytopenic purpura in critical COVID-19.
    Lévesque V; Millaire É; Corsilli D; Rioux-Massé B; Carrier FM
    Int J Hematol; 2020 Nov; 112(5):746-750. PubMed ID: 32613314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teetering on a liver's edge: a case report highlighting clinical decision-making in thrombocytopenia.
    Yan A; Erdman L; Sung L; Bernstein S
    BMC Cancer; 2019 Nov; 19(1):1058. PubMed ID: 31694583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment with belimumab for immune thrombocytopenia associated with systemic lupus erythematosus: A report of two cases.
    Nakayama K; Tamimoto Y; Nakayama T
    Mod Rheumatol Case Rep; 2023 Dec; 8(1):69-73. PubMed ID: 37718578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP).
    Hong J; Bang SM; Mun YC; Yhim HY; Lee J; Lim HS; Oh D;
    J Korean Med Sci; 2018 May; 33(19):e142. PubMed ID: 29736158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical analysis of pregnancy complicated with severe thrombocytopenia].
    Wang DP; Liang MY; Wang SM
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jun; 45(6):401-5. PubMed ID: 21029587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Challenges and potential solutions in first-line treatments for immune thrombocytopenia in adults].
    Godeau B; Bonnotte B; Michel M
    Rev Med Interne; 2021 Jan; 42(1):25-31. PubMed ID: 32713675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of IVIG response in relation to Th1/Th2 cytokines in pediatricm immune thrombocytopenia.
    Chen YY; Zhou YQ; Zhao N; Zhang Y; Xu WQ; Tang YM
    Cytokine; 2019 Aug; 120():234-241. PubMed ID: 31129375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].
    Sato K; Anayama M; Sumi M; Kobayashi H
    Rinsho Ketsueki; 2021; 62(12):1688-1693. PubMed ID: 35022338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
    Kolonić SO; Patekar MB; Milunović V
    Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.